Finally, by preventing formation of extracellular adenosine, tenofovir induces osteopenia in mice, which can be reversed by administration of dipyridamole, an agent that blocks purine uptake via ent1 and thereby increases extracellular adenosine [45]. Here, SLC29A1 is linked to Osteopenia.